AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
ACB   11.77 (-3.21%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
ACB   11.77 (-3.21%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
ACB   11.77 (-3.21%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
ACB   11.77 (-3.21%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
Log in

NASDAQ:ONTXOnconova Therapeutics News Headlines

$0.56
-0.02 (-3.21 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.55
Now: $0.56
$0.58
50-Day Range
$0.36
MA: $0.51
$0.61
52-Week Range
$0.10
Now: $0.56
$2.87
Volume116,604 shs
Average Volume13.82 million shs
Market Capitalization$94.69 million
P/E RatioN/A
Dividend YieldN/A
Beta2.18

Headlines

Onconova Therapeutics (NASDAQ ONTX) News Headlines

Source:
DateHeadline
Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDSOnconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS
finance.yahoo.com - July 7 at 8:31 AM
Onconova Therapeutics (NASDAQ:ONTX) Coverage Initiated by Analysts at Maxim GroupOnconova Therapeutics (NASDAQ:ONTX) Coverage Initiated by Analysts at Maxim Group
www.americanbankingnews.com - June 24 at 7:00 AM
Onconova Initiates Phase I/IIa Study on Lung Cancer CandidateOnconova Initiates Phase I/IIa Study on Lung Cancer Candidate
finance.yahoo.com - June 23 at 2:34 PM
Onconova Therapeutics Announces Participation in Noble Capital Markets Investor WebinarOnconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
finance.yahoo.com - June 23 at 9:34 AM
Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung AdenocarcinomaOnconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma
finance.yahoo.com - June 22 at 8:52 AM
Onconova Therapeutics (ONTX) "Buy" Rating Reiterated at Noble FinancialOnconova Therapeutics' (ONTX) "Buy" Rating Reiterated at Noble Financial
www.americanbankingnews.com - June 16 at 7:30 AM
Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
finance.yahoo.com - June 12 at 9:58 AM
Onconova Therapeutics Announces Presentation at BIO Digital 2020Onconova Therapeutics Announces Presentation at BIO Digital 2020
finance.yahoo.com - June 8 at 12:51 PM
3 “Strong Buy” Penny Stocks That Offer Massive Potential Gains3 “Strong Buy” Penny Stocks That Offer Massive Potential Gains
finance.yahoo.com - May 28 at 12:13 PM
Edited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMTEdited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMT
finance.yahoo.com - May 18 at 2:02 PM
Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial ResultsOnconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
www.benzinga.com - May 14 at 6:47 PM
Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial ResultsOnconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 6:47 PM
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, DenmarkOnconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
finance.yahoo.com - May 12 at 11:29 PM
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of StockholdersOnconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 11 at 10:48 AM
Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020
finance.yahoo.com - May 7 at 6:16 PM
Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry VeteranOnconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran
finance.yahoo.com - April 27 at 10:48 AM
Edited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMTEdited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMT
finance.yahoo.com - April 1 at 4:51 PM
Onconova completes enrollment in late-stage rigosertib study; shares up 16% after hoursOnconova completes enrollment in late-stage rigosertib study; shares up 16% after hours
seekingalpha.com - March 24 at 7:37 PM
Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial ResultsOnconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial Results
www.globenewswire.com - March 24 at 7:37 PM
Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial ResultsOnconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results
finance.yahoo.com - March 18 at 8:50 AM
Will Onconova Therapeutics Continue to Surge Higher?Will Onconova Therapeutics Continue to Surge Higher?
finance.yahoo.com - March 13 at 2:37 PM
Onconova (ONTX) to Report Q4 Earnings: Whats in Store?Onconova (ONTX) to Report Q4 Earnings: What's in Store?
www.nasdaq.com - March 2 at 12:17 PM
Onconova (ONTX) to Report Q4 Earnings: What's in Store?Onconova (ONTX) to Report Q4 Earnings: What's in Store?
finance.yahoo.com - March 2 at 12:17 PM
Onconova: The Ingredients For Success Are Finally HereOnconova: The Ingredients For Success Are Finally Here
seekingalpha.com - February 27 at 1:06 PM
Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue?Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue?
finance.yahoo.com - February 20 at 1:17 PM
The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona TherapeuticsThe Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics
finance.yahoo.com - February 19 at 12:04 PM
Onconova Therapeutics Announces Participation in Two Upcoming International ConferencesOnconova Therapeutics Announces Participation in Two Upcoming International Conferences
finance.yahoo.com - February 18 at 9:49 AM
8 Healthcare Stocks Moving In Tuesdays Pre-Market Session8 Healthcare Stocks Moving In Tuesday's Pre-Market Session
www.msn.com - February 11 at 8:48 AM
Onconova Therapeutics to Present Update at Noble Capital Markets’ Sixteenth Annual Investor Conference in Hollywood, FLOnconova Therapeutics to Present Update at Noble Capital Markets’ Sixteenth Annual Investor Conference in Hollywood, FL
www.globenewswire.com - February 10 at 8:34 AM
Onconova Therapeutics to Present Update at Noble Capital Markets’ Sixteenth Annual Investor Conference in Hollywood, FLOnconova Therapeutics to Present Update at Noble Capital Markets’ Sixteenth Annual Investor Conference in Hollywood, FL
finance.yahoo.com - February 10 at 8:34 AM
Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York CityOnconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City
finance.yahoo.com - February 4 at 8:43 AM
Onconova shares rise after company regains rights to drug in ChinaOnconova shares rise after company regains rights to drug in China
finance.yahoo.com - January 23 at 11:17 PM
BRIEF-Onconova Therapeutics Regains Rigosertib Rights In Greater ChinaBRIEF-Onconova Therapeutics Regains Rigosertib Rights In Greater China
www.msn.com - January 23 at 5:28 PM
Onconova Therapeutics Regains Rigosertib Rights in Greater ChinaOnconova Therapeutics Regains Rigosertib Rights in Greater China
finance.yahoo.com - January 23 at 5:28 PM
BRIEF-Onconova Therapeutics- Received A Public Reprimand Letter From Nasdaq StaffBRIEF-Onconova Therapeutics- Received A Public Reprimand Letter From Nasdaq Staff
www.msn.com - January 17 at 6:47 PM
Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-MarketOnconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market
www.globenewswire.com - January 3 at 2:54 PM
Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-MarketOnconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market
finance.yahoo.com - January 3 at 2:54 PM
Bucks County biopharm firm plans $10M stock saleBucks County biopharm firm plans $10M stock sale
finance.yahoo.com - January 2 at 5:15 PM
Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-MarketOnconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market
www.globenewswire.com - December 31 at 3:46 PM
Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-MarketOnconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market
finance.yahoo.com - December 31 at 3:46 PM
Onconova Therapeutics, Inc. (ONTX) Is Burning These Hedge FundsOnconova Therapeutics, Inc. (ONTX) Is Burning These Hedge Funds
finance.yahoo.com - December 23 at 10:26 PM
Specialised Therapeutics Signs Exclusive Deal for New Haematology DrugSpecialised Therapeutics Signs Exclusive Deal for New Haematology Drug
www.prnewswire.com - December 18 at 2:10 PM
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-MarketOnconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - December 18 at 2:10 PM
Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New ZealandOnconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand
finance.yahoo.com - December 18 at 9:09 AM
Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in BrazilOnconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in Brazil
finance.yahoo.com - December 17 at 8:01 AM
Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-MarketOnconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - December 10 at 7:26 PM
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-MarketOnconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - December 9 at 12:48 PM
Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical Trial Design at the American Society of Hematology 2019 Annual MeetingOnconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical Trial Design at the American Society of Hematology 2019 Annual Meeting
finance.yahoo.com - December 9 at 12:48 PM
Onconova up 24% premarket on rigosertib access programOnconova up 24% premarket on rigosertib access program
seekingalpha.com - December 6 at 2:42 PM
Benzinga Pros Top 5 Stocks To Watch For Fri., Dec. 6, 2019: TSLA, ONTX, XHB, BIG, SFIXBenzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 6, 2019: TSLA, ONTX, XHB, BIG, SFIX
finance.yahoo.com - December 6 at 2:42 PM
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.